137 related articles for article (PubMed ID: 38103844)
1. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
[TBL] [Abstract][Full Text] [Related]
2. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
4. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
5. Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease-related liver cancer by AKT.
Li S; Hao L; Deng J; Zhang J; Hu X
Chem Biol Drug Des; 2023 Oct; 102(4):828-842. PubMed ID: 37460115
[TBL] [Abstract][Full Text] [Related]
6. Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis.
Zhang K; Yuan Y; Dawa Z; Liu F; Yao Y; Wang M; Zhu C; Lin C
J Ethnopharmacol; 2022 Jul; 293():115268. PubMed ID: 35398502
[TBL] [Abstract][Full Text] [Related]
7. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation.
Liu G; Yang L; Tang Y; Lin J; Wang F; Shen J; Chang B; Kong X
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117330. PubMed ID: 37863399
[TBL] [Abstract][Full Text] [Related]
8. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
Yang H; Wei D; Zhang Y; Jian W
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
[TBL] [Abstract][Full Text] [Related]
9. Network pharmacology and experimental verification reveal the mechanism of Hedysari Radix and Curcumae Rhizoma with the optimal compatibility ratio against colitis-associated colorectal cancer.
Zhang Y; Wang Y; Xin E; Zhang Z; Ma D; Liu T; Gao F; Bian T; Sun Y; Wang M; Wang Z; Yan X; Li Y
J Ethnopharmacol; 2024 Mar; 322():117555. PubMed ID: 38110130
[TBL] [Abstract][Full Text] [Related]
10. Corydalis saxicola Bunting Total Alkaloids ameliorate diet-induced non-alcoholic steatohepatitis by regulating hepatic PI3K/Akt and TLR4/NF-κB pathways in mice.
Wu J; Chen P; Ju L; Gao R; Li S; Huang Z; Cheng Y; Gui S; Qiu Z; Cheng J; Huang F
Biomed Pharmacother; 2022 Jul; 151():113132. PubMed ID: 35623174
[TBL] [Abstract][Full Text] [Related]
11. Integrating network pharmacology and in vivo experimental validation to reveal the alleviation of mailuoning oral liquid on non-alcoholic fatty liver disease.
Jia W; Wang K; Zhang S; Lu W; Du A; Li J; Ji L; Xu H
Phytomedicine; 2022 Sep; 104():154326. PubMed ID: 35853303
[TBL] [Abstract][Full Text] [Related]
12. Jatrorrhizine from Rhizoma Coptidis exerts an anti-obesity effect in db/db mice.
He H; Deng J; Yang M; An L; Ye X; Li X
J Ethnopharmacol; 2022 Nov; 298():115529. PubMed ID: 35835345
[TBL] [Abstract][Full Text] [Related]
13. A Plantaginis Semen-Coptidis Rhizoma compound alleviates type 2 diabetic mellitus in mice via modulating AGEs-RAGE pathway.
Liu P; Yan X; Pu J; Liao Q; Wang K; Lan J; Wang R; Wang Z; Ding L; Yang L
J Ethnopharmacol; 2023 Aug; 312():116290. PubMed ID: 36933875
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effect and mechanism of non-polysaccharide fraction of Bletillae Rhizoma in treatment of gastric ulcer based on network pharmacology and animal experiment].
Fang JX; Zhang L; Li J; Zhang HR; Liu D; Nie J; Ye XC
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4446-4458. PubMed ID: 37802871
[TBL] [Abstract][Full Text] [Related]
15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
16. Combining transcriptomics and network pharmacology to reveal the mechanism of Zuojin capsule improving spasmolytic polypeptide-expressing metaplasia.
Xiong M; Chen X; Wang H; Tang X; Wang Q; Li X; Ma H; Ye X
J Ethnopharmacol; 2024 Jan; 318(Pt B):117075. PubMed ID: 37625606
[TBL] [Abstract][Full Text] [Related]
17. The mechanism and experimental verification of Ixeris sonchifolia promoting apoptosis of hepatocellular carcinoma based on network pharmacology: Ixeris sonchifolia Induces Hepatocellular Carcinoma Apoptosis via the PI3K/AKT Pathway.
Liu BJ; Guan YY; Qiao LX; Zhang JM; Li AJ; Yang PX; Gao YX; Chen DX; Wang CX; Wu J
J Ethnopharmacol; 2024 Jun; 327():117994. PubMed ID: 38437889
[TBL] [Abstract][Full Text] [Related]
18. Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.
Zhou W; Zhu Z; Xiao X; Li C; Zhang L; Dang Y; Ge G; Ji G; Zhu M; Xu H
Biomed Pharmacother; 2021 Nov; 143():112181. PubMed ID: 34649337
[TBL] [Abstract][Full Text] [Related]
19. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacology analysis and experimental validation of
Li D; Hu Y; Liu X; Yu G
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):84-97. PubMed ID: 38105702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
